INSERT INTO sites(host) VALUES('') 2002: Can't connect to local MySQL server through socket '/var/run/mysqld/mysqld.sock' (2) 网站价值¥48,310(不含域名),MYIP.CN网站综合数据统计 - 域名,Alexa,PR,反向链接,关键字
  测网速 网站优化诊断 广告招商QQ3066631932 CodeForge最好的源码站!   手机测速 测速APP



sponsored links:
sponsored links:


网站估价:  (注:不包含域名价值,不代表公司价值)


Google Page Rank:
真假PR鉴别:   (提示:若此处显示网站与查询网站不同,则疑为劫持PR)
Sogou Rank:






Name Server:
Whois Server:

Alexa 排名走势数据

流量统计: 当日 一周平均 三个月平均




Alexa 排名走势图

Alexa Reach走势图

域名 Whois 记录

Who is at


Visit for more information about">AboutUs:

Registration Service Provided By:

Contact: support


Domain name:

Registrant Contact:


WhoisGuard Protected ()


8939 S. Sepulveda Blvd. #110 - 732

Westchester, CA 90045


Administrative Contact:


WhoisGuard Protected (


Fax: +1.6613102107

8939 S. Sepulveda Blvd. #110 - 732

Westchester, CA 90045


Technical Contact:


WhoisGuard Protected (


Fax: +1.6613102107

8939 S. Sepulveda Blvd. #110 - 732

Westchester, CA 90045



Name Servers:

Creation date:
17 May 2007 17:34:00

Expiration date: 17 May 2012 17:34:00

Get Noticed on the Internet! Increase visibility for this domain name by listing it at


The data in this whois database is provided to you for information

purposes only, that is, to assist you in obtaining information about or

related to a domain name registration record. We make this information

available "as is," and do not guarantee its accuracy. By submitting a

whois query, you agree that you will use this data only for lawful

purposes and that, under no circumstances will you use this data to: (1)

enable high volume, automated, electronic processes that stress or load

this whois database system providing you this information; or (2) allow,

enable, or otherwise support the transmission of mass unsolicited,

commercial advertising or solicitations via direct mail, electronic

mail, or by telephone. The compilation, repackaging, dissemination or

other use of this data is expressly prohibited without prior written

consent from us.

We reserve the right to modify these terms at any time. By submitting

this query, you agree to abide by these terms.

Version 6.3 4/3/2002


sponsored links:


国内Ping速度测试      国内TraceRoute路由测试
美国Ping速度测试      美国TraceRoute路由测试

网站关键字指数 (越高越热门)

域名 fiercepharma 其他后缀注册情况   查看更多

后缀 注册时间 到期时间 是否注册


0RISMedia Real Estate News, Industry Trends, Marketing
162,827"Спортын цонх" онлайн сэтгүүл R
255,307Pharma News, Pharma Industry, Pharmaceutical News – FiercePharma
227,147Pharmaceutical Companies, News and Information > Pharmaceutical Intern
511,254Event Industry News - An online magazine and news blog for people with
1,245,528NewscastStudio | Television news set design, graphics and industry res
468,453Pharmaceutical industry and manufacturer - Pharmaceutical news, packag
963, is your Free Press release Distribution Center fo
191,013Dr.Reddy's Pharmaceutical Company, Pharma Products, Pharma Research &a
965,218Technology News, Industry Research - Computer Business Review
867,879Pharmaceutical Sales Jobs Minority Jobs Pharma Diversity Job Board
818,116kirk lapointe's journalism and the news industry
195,203Your Industry News: Global Industry, Manufacturing & Project News
822,371Printing News, Industry Information, Features, Community, and Events a
958,615AstraZeneca Canada - prescription drugs, pharmaceutical companies, ind
525,976World Pharma News / Published News
243,229Ranbaxy Laboratories Limited, India : Pharmaceuticals Business, pharma
628,161Pharmaceutical Jobs - Sales, Healthcare & Science Jobs - Pharma
178,353Pharmaceutical Sales Jobs Minority Jobs Pharma Diversity Job Board
111, • Daily Internet News • Самое интересное
279,006business news india pharma power industry real estate travel tourism h
879,596Pharmaceutical Jobs - Pharmaceutical Recruitment - Hays Pharma
272,598Life Science Articles | Pharma News Asia | Life Science News – Biospe
6,715,409Chemlink: The Directory of Global Supplier for Pharmaceutical and Chem
359,989Pharmaceutical Industry | Processing & Engineering: Knowledge, News an
124,052FMQB: Radio Industry News, Music Industry Updates, Arbitron Ratings, M
191,723Pharmaceutical News, Pharmaceutical Articles, and Pharmaceutical Jobs
594, - Mystery shopping news - 亦桧耱忮眄
73,352Computer Business Review
0Pharmaceuticals News - Pharmaceutical Industry Today - News Media Moni


Title:Pharma News, Pharma Industry, Pharmaceuticals Industry – !site_name
Description:Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.
Keywords:Pharmaceutical News,Pharma News,Pharma Industry,Pharmaceutical Industry News,Pharma,Pharma Company,Pharmaceutical Company,FDA regulation,FDA news,Big Pharma,Pharmaceutical Marketing,Pharmaceutical Contract Manufacturing,Pharmaceutical Industry
Pharma News, Pharma Industry, Pharmaceuticals Industry – !site_name
Advertise | Contact
Free Newsletter
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join thousands of pharma industry leaders who get FiercePharma via daily email. Sign up today!
Email address: *
About | View Sample | Privacy
Hottest Products
Compare Top Solutions in:
Clinical Trial Management Software (CTMS)
Pharmaceutical Drug Development
Clinical Research Organizations (CRO)
Monoclonal Antibodies
Polyclonal Antibodies
Drug Safety Information
Evaluate more than 400,000 products 
Featured Jobs
Innovations Adviser Xpedite Innovations Management - London, UK
Opportunity Development Manager – Northern California/Northwestern Territory The Jackson Laboratory - Northern CA/Northwest region of US Canada
Health Economics Consultant Xcelerate Health Outcomes - London, UK
Medical Product Manager Xpedite Innovations Management - London, UK
Opportunity Development Manager – New England/Eastern Canada The Jackson Laboratory - Northern Massachusetts
More Jobs gt; gt;
Popular Topics
PfizerGlaxoSmithKlineFDAMerckEli Lillydrug safetyAstraZenecaNovartisSanofi-AventisRochepharmaceutical layoffsAmgenJohnson amp; JohnsonFDA approvalMore tags...
2011 PDA Analytical Methods Development Validation WorkshopJune 20-21, 2011 #8212; Hyatt Regency Bethesda - Bethesda, MD 8th Annual World Health Care Congress (WHCC)April 4-6, 2011MDMA 17th Annual Meeting June 8-10, 2011 #8212; Washington, D.C.2011 PDA/FDA Pharmaceutical Supply Chain ConferenceJune 6-7, 2011 #8212; Bethesda North Marriott Hotel - Bethesda, MarylandMore Events gt; gt;
Free Newsletter
Free Daily FiercePharma Newsletter:
About | View Sample | Privacy
FEATURES gt; gt; Top 15 Pharma R D Budgets
Latest News
Teva, P amp;G aim to quadruple OTC sales with JV
Teva Pharmaceutical Industries is joining the parade of drugmakers looking to pump up in consumer healthcare. The Israeli company has teamed up with Procter amp; Gamble in a joint venture, which will combine well-known P amp;G over-the-counter brands such as Vicks and Pepto-Bismol with Teva's OTC cold, cough, pain and digestive meds. Report
Latest News
March 31, 2011
Valeant has room to move on Cephalon price
Jury: Abbott breached GSK deal, but not competition law
Supreme Court weighs generic labeling case
Merck pays 2,000-plus docs $20.4M for speaking
J amp;J splits off troubled consumer-drug unit
CMS payment plan confirms coverage for Provenge
March 30, 2011
Merck KGaA tries again on Erbitux for lung cancer
NICE nixes Bristol #039;s arthritis med for NHS use
FDA thwarts KV #039;s over-the-top pricing on Makena
GSK partner holds off generic rival for Lovaza
More news
Also Noted
@FiercePharma: GSK partner holds off generic rival for Lovaza. News | Follow @FiercePharma
gt; The FDA has once again postponed the release of its first draft guidance for pharma's use of social media. Report
gt; Dainippon Sumitomo inked a licensing deal that gives Takeda Pharmaceutical exclusive marketing rights to its antipsychotic drug Latuda in most of Europe, the Nikkei business daily reported. Report
gt; Sanofi-Aventis lost a bid to dismiss a U.S. lawsuit launched by an investor for allegedly withholding information on its flopped anti-obesity pill Acomplia, which was once seen as a potential blockbuster. News
gt; Par Pharmaceutical reached a $1.7 million settlement with the state of Idaho to resolve a dispute over inflated wholesale drug prices. StoryRead more gt; gt;
Press Releases
New Data Analyses with VICTRELIS™ (boceprevir), Merck #039;s Investigational Medicine, Examined Possible Predictors of Sustaine
Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010
The Explosive Specialty Pharmaceuticals Market: Who Gets, Who Pays, Who Decides?
Investigational Direct-Acting Antiviral BMS-790052 Plus PEG-Interferon Alfa and Ribavirin Achieved Up to 92% Sustained Vir
Reportlinker Adds Will Anyone Crack the Obesity Drug Market?
GSK Publishes Payments for Research, Consulting and Advising by U.S. Healthcare Professionals
More Press Releases gt; gt;
Submit a press release
Latest Comments
Provenge at gt;$90k--get out your slide rules k...I am an active and long term member of the ph...SEC: $3.6M biotech trading windfall was engin...Now the question many of us really w...Geez - if all I had to do was fill out quot;relev...I worked at J amp;J for years and I can tell you ...We priced our IPO Dec 16 2010 though we don #039;t...
Making sense of the Alzheimer #039;s drug pipeline
According to the Alzheimer's Association, deaths attributed to the disease have increased by more than 46 percent between 2000 and 2006. Today, in the United States alone, 5.3 million people have Alzheimer's disease, and its annual cost is $172 billion. What new answers has medical science has come up with? At best, it's good news and bad news. Medical progress marches on in its usual lurching way--many failures mixed with some progress. Here's a rundown of what's on the market, recent drug failures, pipeline prospects and the most recent research from the the laboratory trenches. Article
Pfizer vaccine unit eyes adults, infectious disease
When Pfizer was searching for a major acquisition in 2009, it saw a lot it liked in Wyeth--including an established vaccine group that could jump-start its own efforts in that area. After the buy, the world's largest drugmaker found itself with a pipeline of new vaccine candidates and another valuable asset: Dr. Emilio Emini, a noted vaccine researcher who spent 22 years at Merck doing HIV research and working on such blockbusters products as Zostavax, RotaTeq and Gardasil. When Pfizer and Wyeth joined, Emini found himself at the head of the new vaccine division, and the world's largest drugmaker has even bigger plans for its vaccine division. Report
Special Report
The Top 10 Pharma Layoffs of 2010
As 2010 comes to an end, and the year's layoff total tops 50,000, we're releasing our fourth annual layoffs list, highlighting the 10 largest job cut announcements by company. AstraZeneca takes the top spot this year, marking the third time in four years the drugmaker has made our layoffs list. And after two years on top, Pfizer has fallen to second place as it continues to integrate with Wyeth. As Big Pharma prepares for the patent cliff, many blamed their increasing job cuts on pharma's new focus: emerging markets. Some buffered the impending job losses with transfers and jobs created in new markets. Full Report
Pharma Manufacturing News
Indian officials trip over 2D tracking codesAZ, BMS, Lilly, Pfizer make investor's cutBMS, Pfizer offload logistics to willing shippers GSK plies savings from green initiativesPallet-maker war goes publicMore gt; gt;
Biotech News
U.S. biotechs look to bullish Tel Aviv exchange for IPOsAcacia Pharma rounds up $10M in Series ATwo new hep C drugs garner rave reviews ahead of approval Generex maps plan for immunotherapy spinoff, reverse stock splitValeant vows to restructure Cephalon as it moves in for the killMore gt; gt;
Biotech Research News
Nanoparticles help detect circulating tumor cellsResearchers: Early MS nerve cell damage can be reversedNicotine: A guilty party in diabetes complicationsNew laser technique may make drug discovery easierAsthma drug takes care of tricky Alzheimer's enzymeMore gt; gt;
Vaccines News
Gates funds two Indian vaccine firmsInterview: VaxInnate plots its future following HHS contractResearchers work towards seafood allergy vaxPfizer's Prevnar and Sanofi's ActHIB cleared for Japanese marketFDA approves Merck's Zostavax for more adultsMore gt; gt;
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipelineBiosimilars: A Physician PerspectiveAPI in Capsule: Common "First in Man" approaches vs. The Lost Art of Formulation Development Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?Commercial Insight: Top 20 Cancer Therapy BrandsDisplacement Chromatography Comes of Age - An indispencable tool for the purification of biomacromoleculesMore Whitepapers gt; gt;
Paid Research Reports
Trends in mHealth and TelemedicineThe Global Aesthetic Dermatology Market OutlookFuture Directions in Regenerative MedicinePipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractivePipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitorForecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipelineMore Research Reports gt; gt;
| Subscribe | Advertise | Mobile Edition | RSS |
| Site Map
| Editors | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance
| FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance
| FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement
| FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless
| FierceDeveloper | FierceMobileContent | FierceWireless |
FierceWireless:Europe | FierceCable
copy; 2011 FierceMarkets. All rights reserved.




桌面软件: MyIP网站信息状态条  WebShot网页快照  SiteMapMaker网站地图生成 
网站信息: Alexa排名查询  PageRank查询/真假PR鉴别/PR劫持检测  外链检查  搜索引擎收录  搜索引擎反向链接  域名注册查询 
网页编辑: 颜色代码选择器  Html特殊符号 
网站调试: 蜘蛛抓取模拟  网站Header信息  网页源代码查看 
代码转换: 火星文查询  繁体/简体转换  Html/js代码转换  Html/UBB代码转换 
友情连接: CodeForge免费源码 PCFans IT资讯 Ngnix Lighttpd GPhone中国    更多... (PR<5自动转内页)
网站地图: 1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 250 300 350 400 450 500
免责声明 | 联系我们 | 交换友情链接 | 广告位招商QQ: 1967659002
© 2009 Dev by MYIP Elapsed:58.415ms 黑ICP备09072263号